A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2002
11/14/2002	CA2445049A1 Rapidly cleavable sumo fusion protein expression system for difficult to express proteins
11/14/2002	CA2444736A1 Skin treatment
11/14/2002	CA2442969A1 Methods for selective immunomodulation using pimecrolimus
11/14/2002	CA2441417A1 Human secreted proteins
11/14/2002	CA2440575A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
11/14/2002	CA2438978A1 Isolated nucleic acid molecules encoding a novel human signal transducing kinase-mapkap-2; encoded proteins, cells transformed therewith and uses thereof
11/14/2002	CA2435142A1 Kinases and phosphatases
11/13/2002	EP1256354A1 Methods for treating cancer
11/13/2002	EP1256352A2 Immunomodulatory peptides
11/13/2002	EP1256283A2 Phytopharmaceutical food products
11/13/2002	EP1255993A2 Methods for identifying modulators for balance related disorders
11/13/2002	EP1255869A1 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255864A1 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255850A1 AMPLIFICATION OF $i(CYP24) AND USES THEREOF
11/13/2002	EP1255845A2 Modified cytokines for use in cancer therapy
11/13/2002	EP1255844A1 Humanized anti-ccr2 antibodies and methods of use therefor
11/13/2002	EP1255842A1 Larynx carcinoma-associated protein larcap-1
11/13/2002	EP1255837A2 Il-17 like molecules and uses thereof
11/13/2002	EP1255836A2 Novel, central nervous protein, that modulates k?+ flows
11/13/2002	EP1255835A2 Polypeptides and nucleic acids encoding same
11/13/2002	EP1255834A2 Gtpase activating proteins
11/13/2002	EP1255833A2 Polypeptides and nucleic acids encoding same
11/13/2002	EP1255831A2 Sperm specific proteins
11/13/2002	EP1255829A2 Inhibitor of hepatocyte growth factor activator for use in modulation of angiogenesis and cardiovascularization
11/13/2002	EP1255828A2 Small oligonucleotides with anti-tumor activity
11/13/2002	EP1255827A2 Novel oligonucleotides and use of oligonucleotides modulating the expression of enzymes involved in the synthesis of melanic pigments, as depigmentation agents
11/13/2002	EP1255824A2 Non-human transgenic animals for the study of neurodegenerative syndromes
11/13/2002	EP1255823A1 Slow release protein polymers
11/13/2002	EP1255822A2 Modified adenylylcyclase type vi useful in gene therapy for congestive heart failure
11/13/2002	EP1255821A2 Protein c derivatives
11/13/2002	EP1255820A1 Glucuronoxylomannan (gxm)-o-acetylhydrolase of cryptococcus neoformans and uses thereof
11/13/2002	EP1255819A2 Human kinases
11/13/2002	EP1255817A1 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255778A2 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255777A1 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255776A1 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255774A1 Transgenic animal model for obesity expressing foxc2
11/13/2002	EP1255770A1 Melanin-concentrating hormone analogs
11/13/2002	EP1255769A2 Universal procedure for refolding recombinant proteins
11/13/2002	EP1255768A2 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255767A2 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255766A2 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255748A1 Beta-alanine derivatives and their use as receptor antagonists
11/13/2002	EP1255726A2 (r)-2-aryl-propionamides, useful in the inhibition of il-8 induced chemiotaxis of neutrophils
11/13/2002	EP1255718A1 A substance for the use in a dietary supplementation or for the preparation of a medicament for the treatment of non-insulin dependent diabetes mellitus, hypertension and/or the metabolic syndrome
11/13/2002	EP1255570A2 Matrix metalloproteinase inhibitors as targeting components in diagnostic agents
11/13/2002	EP1255569A2 Method for treating kidney disorders
11/13/2002	EP1255568A2 Conjugates targeted to target receptors
11/13/2002	EP1255560A2 Cd40 ligand adjuvant for respiratory syncytial virus vaccine
11/13/2002	EP1255559A2 Use of inhibitors of caspase-3 or caspase-activated desoxyribonuclease (cad) for treating cardiac disease
11/13/2002	EP1255558A1 Uses of agonists and antagonists to modulate activity of tnf-related molecules
11/13/2002	EP1255557A1 Stable, nasally, orally or sublingually applicable pharmaceutical preparation
11/13/2002	EP1255556A2 Neuroprotective, antithrombotic and anti-inflammatory uses of activated protein c (apc)
11/13/2002	EP1255555A2 NON-MAMMALIAN GnRH ANALOGS AND USES THEREOF IN REGULATION OF FERTILITY AND PREGNANCY
11/13/2002	EP1255554A2 Kidney-specific tumor vaccine directed against kidney tumor antigen g-250
11/13/2002	EP1255548A1 Use of thiostrepton as an anti-mycobacterial agent
11/13/2002	EP1255545A2 L-arginine in combination with other compounds for treating cardiovascular diseases
11/13/2002	EP1255542A1 Substituted amino acids as neutral sphingomyelinase inhibitors
11/13/2002	EP1255534A2 Method for the preparation of microspheres which contain colloidal systems
11/13/2002	EP1255456A1 Use of glutamate and/or a glutamate precursor for the preparation of a nutritional or pharmaceutical preparation for the treatment or prevention of hyperpermeability or undesired permeability of the intestinal wall
11/13/2002	EP1255452A2 A method for maintaining or improving the synthesis of mucins
11/13/2002	EP1113811B1 Chemokine receptor antagonist and cyclosporin in combined therapy
11/13/2002	EP1086092B1 BENZO(b)THIEPINE-1,1-DIOXIDE DERIVATIVES, A METHOD FOR THE PRODUCTION THEREOF, MEDICAMENTS CONTAINING THESE COMPOUNDS, AND THEIR USE
11/13/2002	EP1084146B1 Hybrid protein for inhibiting the degranulation of mastocytes and the use thereof
11/13/2002	EP1060261A4 Poly zinc finger proteins with improved linkers
11/13/2002	EP1025851B1 Alpha-glucosidase inhibitor
11/13/2002	EP1012162B1 Soluble proteins
11/13/2002	EP1007078A4 Peptidomimetics containing 6-peptidylamino-1-naphthalenesulfonamide moieties
11/13/2002	EP0891378B1 Use of a pharmaceutical composition comprising an appetite-suppressing peptide
11/13/2002	EP0843557B1 Methods for detecting, identifying, isolating, and selectively labelling and targeting th1 lymphocytes by means of the lag-3 protein
11/13/2002	EP0738281B1 Peptides and their uses against psoriasis
11/13/2002	EP0699074B1 Thrombin inhibitors
11/13/2002	EP0697889B1 COMBINED TREATMENT OF IRON DEPLETION AND IgG ANTIBODY
11/13/2002	EP0693940B1 Hybrid genes for use in the production of t h?-independent cytotoxic t cells
11/13/2002	EP0693935B1 Method and compositions for digesting tissue
11/13/2002	EP0671926B1 Immunomodulatory peptides
11/13/2002	EP0618807B1 A stabilized pharmaceutical formulation comprising growth hormone and histidine
11/13/2002	CN1379819A Catalytically active recombinant MEMAPSIN and methods of use thereof
11/13/2002	CN1379817A Composition and methods for increasing cholesterol efflux and raising HDL using ATP binding cassettte ttansporter protein ABC1
11/13/2002	CN1379816A Human G-protein coupled receptor
11/13/2002	CN1379815A BAFF receptor (BCMA), immunoregulatory agent
11/13/2002	CN1379786A Modified peptides and peptidomimetics for use in immunotherapy
11/13/2002	CN1379785A Caspase inhibitors for treatment and prevention of chemotherapy and radiation therapy induced cell death
11/13/2002	CN1379782A Subunit optimized fusion proteins
11/13/2002	CN1379685A Novel method and composition for inhibition of angiogenesis using antagonists based on MMP-9 and beta integrins
11/13/2002	CN1379681A therapeutic angiogenic factors and methods for their use
11/13/2002	CN1379680A New class of bioactive glycoprotein
11/13/2002	CN1379679A Methods for treating pain
11/13/2002	CN1379669A Valdecoxib compositions
11/13/2002	CN1379664A Activation and protection of cytotoxic lymphocytes using reactive oxygen metabolite inhibitor
11/13/2002	CN1379047A Match of organic medicine and beta-cyclodextrin derivative and its preparing process
11/13/2002	CN1379042A Scorpion peptide for treating arrhythmia and its preparing process and application
11/13/2002	CN1379041A Cytotoxin T lymphocyte
11/13/2002	CN1378863A Active casein phosphopeptide and its preparing process
11/12/2002	US6479655 TNF receptor promoter
11/12/2002	US6479654 Forms of the angiogenic factor vascular endothelial cell growth factor: VEGF
11/12/2002	US6479653 Compositions and method for regulation of transcription
11/12/2002	US6479643 Single chain analogs of the TGF-β superfamily (morphons)
11/12/2002	US6479642 Cortistatin: neuropeptides
11/12/2002	US6479639 Monoclonal antibody to a human MDR1 multidrug resistance gene product and uses

1 ... 1958 1959 1960 1961 1962 1963 1964 1965 1966 1967 1968 1969 1970 1971 1972 1973 1974 1975 1976 1977 1978 ... 3163